Effectiveness of Ixekizumab in Elderly Patients for the Treatment of Moderate-to-Severe Psoriasis: Results From a Multicenter, Retrospective Real-Life Study in the Lazio Region.

Annunziata DattolaNicoletta BernardiniGiacomo CaldarolaRosa CoppolaClara De SimoneDomenico GiordanoAlessandro GiuntaGaia MorettaGianluca PagnanelliVincenzo PanasitiSeverino PersechinoConcetta PotenzaFederica TrovatoArianna ZangrilliLuca BianchiGiovanni PellacaniKetty PerisAntonio Giovanni Richetta

Published in: Dermatology practical & conceptual (2024)

Ixekizumab was effective and with a good safety profile in psoriatic patients over 65 years. No significant adverse events were reported.

Keyphrases

end stage renal disease
ejection fraction
randomized controlled trial
rheumatoid arthritis
cross sectional
systematic review
prognostic factors
peritoneal dialysis
ankylosing spondylitis
high intensity
patient reported outcomes
systemic lupus erythematosus
patient reported